Molbio Diagnostics Ltd vs Take Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 23, 2026

Key Highlights

The Latest Trading Price of Molbio Diagnostics Ltd is ₹ 1237 as of 23 Oct 15:30 . The P/E Ratio of Molbio Diagnostics Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Take Solutions Ltd changed from 2.6 on March 2025 to 54.3 on March 2026 . This represents a CAGR of 357.00% over 2 years The Market Cap of Molbio Diagnostics Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Take Solutions Ltd changed from ₹ 664.96 crore on March 2021 to ₹ 586.26 crore on March 2026 . This represents a CAGR of -2.08% over 6 years The revenue of Molbio Diagnostics Ltd for the Jun '26 is ₹ 411.48 crore as compare to the Mar '26 revenue of ₹ 565.41 crore. This represent the decline of -27.22% The revenue of Take Solutions Ltd for the Jun '26 is ₹ 31.7 crore as compare to the Mar '26 revenue of ₹ 59.37 crore. This represent the decline of -46.61% The ebitda of Molbio Diagnostics Ltd for the Jun '26 is ₹ 103.68 crore as compare to the Mar '26 ebitda of ₹ 163.51 crore. This represent the decline of -36.59% The ebitda of Take Solutions Ltd for the Jun '26 is ₹ 1.06 crore as compare to the Mar '26 ebitda of ₹ 4.36 crore. This represent the decline of -75.69% The net profit of Molbio Diagnostics Ltd changed from ₹ -23.94 crore to ₹ 52.74 crore over 5 quarters. This represents a CAGR of NaN% The net profit of Take Solutions Ltd changed from ₹ -3.75 crore to ₹ 1.06 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Molbio Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Take Solutions Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Molbio Diagnostics Ltd

Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited' at Panaji, as a private company dated October 20, 2000.
Thereafter, Company was converted from a private limited company to a public limited company, and the name of Company was changed to Molbio Diagnostics Limited, and a fresh certificate of incorporation dated January 16, 2025 was issued to Company by the RoC. Company is innovative point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
The Company entered into a joint venture agreement in August, 2011 with Bigtec Innovations Private Limited and Bigtec Private Limited, which started operations in 2000.
Bigtec Innovations Private Limited got merged with the Company in 2015.

About Take Solutions Ltd

Take Solutions Limited was incorporated on December 20, 2000.
The Company has been promoted by a team of domain experts in the supply chain management sector of the software industry. TAKE Solutions delivers domain-intensive services and solutions in Life Sciences, Software and Information Technology.
In the fast-growing Life Sciences space, the Company offers clients a unique combination of full-service Clinical, Regulatory and Safety services backed by unique technology expertise.
Its global roster of clients includes large and small innovator biopharmaceutical companies as well as generics manufacturers.
As of March 31, 2025, TAKE Solutions Pte Ltd owned 52.90% of the Company's equity share capital and has the ability to control its operating and financial policies. In Supply Chain Management, TAKE through its subsidiaries focuses on niche engineering services, supply chain collaboration and product re-engineering.

FAQs for the comparison of null and Take Solutions Ltd

Which company has a larger market capitalization, Molbio Diagnostics Ltd or Take Solutions Ltd?

Market cap of Molbio Diagnostics Ltd is 14,262 Cr while Market cap of Take Solutions Ltd is 161 Cr

What are the key factors driving the stock performance of Molbio Diagnostics Ltd and Take Solutions Ltd?

The stock performance of Molbio Diagnostics Ltd and Take Solutions Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Molbio Diagnostics Ltd and Take Solutions Ltd?

As of October 23, 2026, the Molbio Diagnostics Ltd stock price is INR ₹1237.65. On the other hand, Take Solutions Ltd stock price is INR ₹10.93.

How do dividend payouts of Molbio Diagnostics Ltd and Take Solutions Ltd compare?

To compare the dividend payouts of Molbio Diagnostics Ltd and Take Solutions Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.